Partner Article
Salford-based BioClinics gets green light to expand testing
Salford testing firm BioClinics is set for further growth after securing approval to supply its services to several key target markets.
BioClinics conducts its tests by collecting and analysing urine and breath samples. It operates a network of clinics and mobile sample collectors across the UK and Ireland.
The firm has gained accreditations from Achilles Group, which evaluates suppliers on behalf of companies and organisations operating in nearly a dozen sectors.
BioClinics has passed industry audits for its workplace drug and alcohol tests in the transport, rail and utilities sectors.
The accreditations mean BioClinics is now an approved supplier of pre-employment and random tests to the rail and transport sectors, including Network Rail and its sub-contractors, and to utility companies including National Grid and its sub-contractors.
BioClinics experiencing a 470% rise in the number of annual tests it carried out between 2010 and 2013.
Nichola McChrystal, founder and scientific director of BioClinics, said: “We are aiming to double the number of tests we carry out over the next six months. In the longer term, major investment projects such as the HS2 and HS3 rail links should generate even greater demand for our testing services.”
This was posted in Bdaily's Members' News section by Sophia Taha .
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?
What new NPPF rules mean for landowners
The hidden cost squeezing Britain's economy
Teesside deserves more than cashback devolution
Construction must be built on commercial discipline